Roche Group currently has two main research directions and businesses, one is pharmaceuticals, and the second is diagnostics.
The pharmaceutical technology of Roche Group has always been very famous. To give a simple example, during the epidemic of influenza in China, there was a very popular drug called oseltamivir, which is an antiviral drug.
Sourced from Roche Group.
Danio, the current director of the pharmaceutical department, was the one who invited Bona and others to compete with Baiye Research Institute in the field of oncology.
This time, the top management of Roche Group fully agreed with Danio’s actions and even unanimously approved it.
Why?
Because in the past few days, after the news about Roche Group and Bona, Considine, and Mostan came out, they instantly occupied the hot spot of public opinion, which also caused the stock price to rise.
Nothing can be more beneficial than benefits.
Seeing such a response, the current CEO of Roche Group immediately cooperated with Danio's actions and provided strong support in various policies and finances.
We have even invited seven or eight Nobel Prize winners, including Bona and others, and are bound to make great achievements in this field and do great things.
Danio looked at Bona and said with a smile: "Professor Bona, which area do you think it is more appropriate for us to start with?"
Bona put down the documents in his hand, which stated the Roche Group's investment and strong strength in this research: "The field of oncology is very large. Although it is only one subject, this subject basically covers most of the internal medicine."
Cancer exists in every field, and the cell specificity of each system determines that each disease has different differences. This is a relatively complex and difficult task. But... I said
To be honest, I don’t want to study something with Bai Ye, or in other words, I don’t think it would be of any benefit to us to study something with Bai Ye at the same time.”
"It is true that the share price of Roche Group is rising now, but I believe that if we and Bai Ye study something in the same field at the same time, no one can guarantee that one will discover it first. When two tigers compete, one will be injured. This is not wise.
Behavior."
"So, I think we can start with another tumor, that is, conduct research in different directions with Bai Ye. If he studies lung disease, we will study gastric cancer. If he studies glioma, we will study stromal cancer.
Tumor, in short, don’t crash!”
The people present here are all outstanding people. When Bona said what he said, everyone understood what he meant.
Everyone's eyes lit up because Bona's suggestion was very constructive.
After hearing Bona's words, Danio suddenly felt that his money was not wasted and his face was filled with joy. Just like Bona said, no one is God, and no one can guarantee that their research will be better than the other's.
If he and Bai Ye collide, and Bai Ye drives the forklift and he drives the Santana, such a collision can only be called a disaster!
For a listed group like Roche Group, it has a great impact.
After a company goes public, it has to care about reputation, credibility, and many other things, which is not an easy thing.
Danio asked: "Then where do you think we should start? Which field of research should we engage in?"
Bona seemed to have a solution to this problem, but he remained silent for a while, and then slowly said: "Actually, I don't know much about Bai Ye's dynamics, and I really don't know what he will do next.
What kind of research?"
"But, I feel that Bai Ye is likely to start with lung cancer!"
After speaking, Bona opened his laptop, then turned on the projector, and said to everyone: "During this period, I made a detailed report on the market share of Roche Group and Pfizer Group in the field of oncology. You can take a look."
"This report mainly contains several data on the market share, praise rate, and effectiveness of oncology R&D drugs of Pfizer Group and Roche Group within five years. You can clearly see that in terms of market share, Pfizer
The total share of the drug is not much different from that of Roche, but if we look closely at the details and branches of each drug, we can find many problems!"
“In the field of lung cancer, our Roche Group’s current advantages are mainly concentrated on the drug caiis produced ten years ago. However, in the past five years, the comparison results between us and Pfizer’s lung cancer drugs show that the results are 31.212% and 33.211%. Pfizer is better than us.
There are two more percentage points, and these two percentage points don't seem to explain anything. However, after I removed the old drug caiis, I found that we have fallen behind!"
"What does this mean? It means that in the past five years, our drugs for lung cancer have not achieved particularly good market response. This is not a good thing for us. Moreover, the drugs currently used in China
All lung cancer drugs basically come from us, because our established drugs entered developing countries relatively early. Our pharmaceutical groups such as Shanghai Roche Group, Hong Kong Roche Group, and China Roche Group occupy most of the domestic market. However, Pfizer is different.
It occupies the market of developed countries. Here is a proportional chart for everyone to take a look at."
…………
Although Boehner does not have a keen eye, let alone see the technological content of each drug, but with the brain of a scientist, he can obtain a lot of invisible information through a pile of data.
After continuous analysis of this information and data, we can get a lot of useful essence, that is, what is behind the phenomenon.
This is knowledge!
In fact, in the eyes of many people, many things are impossible, but if you can analyze a lot of details and data, you can get a lot of seemingly magical and impossible data. This is ability.
This is also the purpose of education and training.
The education stage is mainly about acquiring knowledge through learning.
The postgraduate and doctoral stages are mainly to teach you how to use the knowledge you have learned to solve many practical problems.
In this regard, major foreign universities have done very well, especially those famous schools with historical heritage, such as the eight major Ivy League schools and so on.
They pay special attention to the cultivation of students in these aspects, and focus on the application of learned knowledge in solving problems.
Therefore, this is also a relatively outstanding aspect in the education of highly educated and high-level talents in foreign universities.
So, don’t think that knowledge is useless, in fact you just don’t know how to use it yet.